Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]

Group 1 - The company Ningbo Huaxiang announced that its subsidiary Huaxiang Qiyuan plans to invest 5 million RMB as a limited partner in the Shanghai Lingzhi New Venture Capital Partnership (Limited Partnership) [1] - The fund will be managed by Zhuhai Hillhouse Private Equity Fund Management Co., Ltd. [1] - The investment focus will be on innovative enterprises related to the embodied intelligence industry chain [1]

宁波华翔公告，公司下属子公司华翔启源拟参与投资上海瓴智新创创业投资合伙企业（有限合伙），其 中华翔启源作为有限合伙人认缴出资500万元。该基金的管理人为珠海高瓴私募基金管理有限公司，该 基金将主要围绕具身智能产业链相关的创新企业进行投资。 ...

Group 1 - The company Ningbo Huaxiang (002048.SZ) announced that its subsidiary, Ningbo Huaxiang Qiyuan Technology Co., Ltd., plans to invest in a venture capital fund focused on the embodied intelligence industry chain [1] - The company will contribute 5 million yuan to the Shanghai Lingzhi New Venture Capital Partnership (Limited Partnership), which has a total fund size of 130 million yuan [1] - Other investors in the fund include Zhiyuan Innovation (Shanghai) Technology Co., Ltd. and Longqi Technology [1]

格隆汇11月24日丨宁波华翔(002048.SZ)公布,2025年11月24日，公司下属子公司宁波华翔启源科技有限 公司拟参与投资上海瓴智新创创业投资合伙企业（有限合伙），其中华翔启源作为有限合伙人认缴出资 500万元人民币。该基金的管理人为珠海高瓴私募基金管理有限公司，该基金将主要围绕具身智能产业 链相关的创新企业进行投资。 ...

人民财讯11月24日电，宁波华翔（002048）11月24日公告，公司下属子公司华翔启源拟参与投资上海瓴 智新创创业投资合伙企业(有限合伙)，其中华翔启源作为有限合伙人认缴出资500万元。该基金的管理 人为珠海高瓴私募基金管理有限公司，该基金将主要围绕具身智能产业链相关的创新企业进行投资。 ...

董事会公告 证券代码:002048 证券简称:宁波华翔 公告编号:2025-079 本公司全体董事、监事、高级管理人员保证公告内容真实、准确和完整，并 对公告中的虚假记载、误导性陈述或者重大遗漏承担责任。 一、对外投资概述 （一）对外投资基本情况 2025 年 11 月 24 日，宁波华翔电子股份有限公司（以下简称"宁波华翔"或"公 司"）下属子公司宁波华翔启源科技有限公司（以下简称"华翔启源"）拟参与投资 上海瓴智新创创业投资合伙企业（有限合伙）（以下简称"基金"、"合伙企业"）， 其中华翔启源作为有限合伙人认缴出资 500 万元人民币。该基金的管理人为珠海高瓴 私募基金管理有限公司，该基金将主要围绕具身智能产业链相关的创新企业进行投资。 根据《深圳证券交易所股票上市规则》《公司章程》等相关规定，本次交易无需 提交董事会、股东会审议通过，不构成关联交易，亦不构成《上市公司重大资产重组 管理办法》规定的重大资产重组。 二、合作方基本情况 （一）普通合伙人、执行事务合伙人、基金管理人 是否与公司存在关联关系：否 宁波华翔电子股份有限公司 关于子公司参与投资创业投资基金的公告 珠海高瓴私募基金管理有限公司为基金的 ...

Core Viewpoint - Ningbo Fangzheng Automotive Mould Co., Ltd. has signed a strategic cooperation agreement with Ningbo Huaxiang Electronics Co., Ltd.'s wholly-owned subsidiary, Ningbo Huaxiang Qiyuan Technology Co., Ltd., to accelerate the development of the general robotics industry and promote innovation in the supply chain and products [2][3] Group 1: Strategic Cooperation - The agreement emphasizes principles of legal compliance, complementary advantages, friendly consultation, and mutual benefit [2] - Both companies will collaborate on core components such as precision structural parts and joint modules, creating a complete development chain from R&D to mass production [2] - Ningbo Fangzheng will provide office and production environments for testing and demonstration of robotic products, while both parties will promote applications in industrial manufacturing, commercial services, and scientific education [2] Group 2: Product Development and Market Expansion - The cooperation will cover various robot types, including bipedal humanoid, wheeled humanoid, quadrupedal, and commercial cleaning robots [2] - Huaxiang Qiyuan will handle demand design and solution confirmation, while Ningbo Fangzheng will focus on process development and manufacturing implementation [2] - The partnership aims to expand downstream application scenarios and leverage Ningbo Fangzheng's precision manufacturing experience to secure high-quality downstream customers, potentially establishing a rapid market share in niche areas [2] Group 3: Business Synergy and Growth Potential - The robotics component business is expected to create technical synergies with existing businesses in automotive molds, automotive parts, lithium battery precision components, and intelligent equipment [3] - This collaboration is anticipated to enhance capacity utilization and scale effects [3] - Long-term, the robotics business may become a new growth curve for the company, providing new momentum for sustained performance growth [3]

Core Viewpoint - Ningbo Fangzheng (300998) has signed a strategic cooperation agreement with Ningbo Huaxiang Qiyuan Technology Co., Ltd. to enhance collaboration in the production and application of general robot components and systems [1] Group 1: Strategic Cooperation - The agreement aims to integrate various R&D and manufacturing resources between the two companies [1] - The focus of the collaboration includes the development and mass production of precision structural components and joint modules for robot products [1] Group 2: Company Background - Huaxiang Qiyuan is a wholly-owned subsidiary established by Ningbo Huaxiang Electronics Co., Ltd., specializing in intelligent robot manufacturing [1]

Core Insights - Ningbo Fangzheng has signed a strategic cooperation agreement with Ningbo Huaxiang Qiyuan Technology to accelerate the development of the general robotics industry and promote supply chain demonstration and product innovation [1] Company Overview - Ningbo Fangzheng's revenue composition for the first half of 2025 is as follows: Other businesses account for 70.29%, while new energy structural components account for 29.71% [1] - As of the report date, Ningbo Fangzheng has a market capitalization of 3.1 billion yuan [1]